Latest Heska Corp (HSKA) Headlines This Company
Post# of 37
Posted On: 03/12/2014 10:09:07 PM
Latest Heska Corp (HSKA) Headlines
This Company's "Dismal" Performance Masks Excellent Opportunity
John Leonard, The Motley Fool - Motley Fool - Fri Feb 14, 1:30PM CST
Abaxis fell sharply after reporting disappointing results last month. However the recent recovery suggests the market is beginning to realize that the cause for the "dismal" results (the CEO's words) is most likely a one-off occurrence rather...
Cambrex (CBM) Jumps: Stock Adds 13.1% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Jan 29, 8:46AM CST
Cambrex Corp. was a big mover last session, with shares rising over 13%.
Heska Corporation to Present at the Sidoti Semi-Annual Micro-Cap Conference
PR Newswire - Wed Jan 08, 8:00AM CST
Heska Corporation (NASDAQ:HSKA - News; "Heska" or the "Company"), a provider of advanced veterinary diagnostic and other specialty veterinary products, today announced that Robert Grieve, chairman and chief executive officer, will present at the Sidoti & Company, LLC Semi-Annual New York Micro-Cap Conference at 10:40 a.m. ET on January 13, 2014 in the Estate 4/Carnegie Hall room at the Grand Hyatt New York Hotel. Heska management will be available during the day for one-on-one meetings. To schedule a meeting, please contact your Sidoti representative.
Peregrine Pharmaceuticals (PPHM) Soars: Stock Adds 14.5% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Jan 07, 7:57AM CST
Peregrine Pharmaceuticals, Inc. (PPHM) was a big mover last session, as the company saw its shares rise over 14% on the day.
MYGN Faces Payment Cuts, Shares Fall - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Jan 06, 2:20PM CST
Shares of Myriad Genetics fell following the announcement by CMS to reduce reimbursement rates on the former's BRACAnalysis test.
Synta Pharmaceuticals Corp. (SNTA) Catches Eye: Stock Surges 11.8% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Jan 06, 7:44AM CST
Synta Pharmaceuticals Corp. was a big mover last session, as the company saw its shares rise nearly 12% on the day.
Synthetic Biologics (SYN) Jumps: Stock Up 5.2% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Jan 03, 7:51AM CST
Synthetic Biologics Inc. was a big mover last session, as its shares rose over 5% on the day.
Immunomedics (IMMU) Jumps: Stock Adds 10.3% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Jan 02, 8:25AM CST
Immunomedics was a big mover last session, with shares rising over 10%.
Pluristem (PSTI) Jumps: Stock Adds 8.6% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Jan 02, 7:37AM CST
Pluristem Therapeutics, Inc. was a big mover last session, as the company saw its shares nearly 9% on the day.
Edwards Lifesciences Lifted to Hold - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Dec 31, 5:26PM CST
On Dec 28, Zacks Investment Research upgraded medical device major, Edwards Lifesciences Corporation to a Zacks Rank #3 (Hold).
AVEO Pharmaceuticals, Inc. (AVEO) Catches Eye: Stock Rises 8% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Dec 31, 7:44AM CST
AVEO Pharmaceuticals, Inc. was a big mover last session, as the company saw its shares rise by 8% on the day.
Genomic Health Remains Neutral - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Dec 27, 12:55PM CST
We reaffirm our long-term Neutral recommendation on Genomic Health following its third-quarter 2013 results.
Supernus Pharmaceuticals, Inc. (SUPN) Worth Watching: Stock Surges 13.2% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Dec 26, 6:44AM CST
Supernus Pharmaceuticals, Inc was a big mover last session, as the company saw its shares rise over 13% on the day.
Synthetic Biologics (SYN) in Focus: Stock Surges 18.1% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Dec 24, 7:25AM CST
Synthetic Biologics was a big mover last session, with shares rising over 18%.
Synergy Pharmaceuticals Catches Eyes: Stock Jumps 8.6% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Dec 24, 6:44AM CST
Synergy Pharmaceuticals, Inc. was a big mover last session, as the company saw its shares rise nearly 9% on the day
Myriad Maintained at Neutral - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Dec 23, 3:45PM CST
On Dec 23, we reaffirmed our long-term Neutral recommendation on Myriad Genetics Inc.
Affymetrix Reaches New 52-Week High - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Dec 23, 1:00PM CST
Shares of Affymetrix started escalating following its promising third quarter results on Oct 30.
Jazz Pharmaceuticals plc (JAZZ) Catches Eye: Stock Rises 8% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Dec 23, 6:44AM CST
Jazz Pharmaceuticals Public Limited Company was a big mover last session, as the company saw its shares gain 8% on the day.
Ariad Pharmaceuticals (ARIA) Worth Watching: Stock Surges 19.7% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Dec 19, 6:44AM CST
Ariad Pharmaceuticals Inc. was a big mover last session, as the company saw its shares jump nearly 20% on the day.
Surging Rank, Surging Stock: Why InSite Vision (INSV) is a Winner? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Dec 18, 6:30AM CST
One company that should be on your radar is InSite Vision Incorporated. The stock of this company has seen its Zacks Rank surge over the past four weeks, moving from Hold to its current position as a Strong Buy.
This Company's "Dismal" Performance Masks Excellent Opportunity
John Leonard, The Motley Fool - Motley Fool - Fri Feb 14, 1:30PM CST
Abaxis fell sharply after reporting disappointing results last month. However the recent recovery suggests the market is beginning to realize that the cause for the "dismal" results (the CEO's words) is most likely a one-off occurrence rather...
Cambrex (CBM) Jumps: Stock Adds 13.1% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Jan 29, 8:46AM CST
Cambrex Corp. was a big mover last session, with shares rising over 13%.
Heska Corporation to Present at the Sidoti Semi-Annual Micro-Cap Conference
PR Newswire - Wed Jan 08, 8:00AM CST
Heska Corporation (NASDAQ:HSKA - News; "Heska" or the "Company"), a provider of advanced veterinary diagnostic and other specialty veterinary products, today announced that Robert Grieve, chairman and chief executive officer, will present at the Sidoti & Company, LLC Semi-Annual New York Micro-Cap Conference at 10:40 a.m. ET on January 13, 2014 in the Estate 4/Carnegie Hall room at the Grand Hyatt New York Hotel. Heska management will be available during the day for one-on-one meetings. To schedule a meeting, please contact your Sidoti representative.
Peregrine Pharmaceuticals (PPHM) Soars: Stock Adds 14.5% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Jan 07, 7:57AM CST
Peregrine Pharmaceuticals, Inc. (PPHM) was a big mover last session, as the company saw its shares rise over 14% on the day.
MYGN Faces Payment Cuts, Shares Fall - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Jan 06, 2:20PM CST
Shares of Myriad Genetics fell following the announcement by CMS to reduce reimbursement rates on the former's BRACAnalysis test.
Synta Pharmaceuticals Corp. (SNTA) Catches Eye: Stock Surges 11.8% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Jan 06, 7:44AM CST
Synta Pharmaceuticals Corp. was a big mover last session, as the company saw its shares rise nearly 12% on the day.
Synthetic Biologics (SYN) Jumps: Stock Up 5.2% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Jan 03, 7:51AM CST
Synthetic Biologics Inc. was a big mover last session, as its shares rose over 5% on the day.
Immunomedics (IMMU) Jumps: Stock Adds 10.3% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Jan 02, 8:25AM CST
Immunomedics was a big mover last session, with shares rising over 10%.
Pluristem (PSTI) Jumps: Stock Adds 8.6% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Jan 02, 7:37AM CST
Pluristem Therapeutics, Inc. was a big mover last session, as the company saw its shares nearly 9% on the day.
Edwards Lifesciences Lifted to Hold - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Dec 31, 5:26PM CST
On Dec 28, Zacks Investment Research upgraded medical device major, Edwards Lifesciences Corporation to a Zacks Rank #3 (Hold).
AVEO Pharmaceuticals, Inc. (AVEO) Catches Eye: Stock Rises 8% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Dec 31, 7:44AM CST
AVEO Pharmaceuticals, Inc. was a big mover last session, as the company saw its shares rise by 8% on the day.
Genomic Health Remains Neutral - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Dec 27, 12:55PM CST
We reaffirm our long-term Neutral recommendation on Genomic Health following its third-quarter 2013 results.
Supernus Pharmaceuticals, Inc. (SUPN) Worth Watching: Stock Surges 13.2% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Dec 26, 6:44AM CST
Supernus Pharmaceuticals, Inc was a big mover last session, as the company saw its shares rise over 13% on the day.
Synthetic Biologics (SYN) in Focus: Stock Surges 18.1% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Dec 24, 7:25AM CST
Synthetic Biologics was a big mover last session, with shares rising over 18%.
Synergy Pharmaceuticals Catches Eyes: Stock Jumps 8.6% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Dec 24, 6:44AM CST
Synergy Pharmaceuticals, Inc. was a big mover last session, as the company saw its shares rise nearly 9% on the day
Myriad Maintained at Neutral - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Dec 23, 3:45PM CST
On Dec 23, we reaffirmed our long-term Neutral recommendation on Myriad Genetics Inc.
Affymetrix Reaches New 52-Week High - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Dec 23, 1:00PM CST
Shares of Affymetrix started escalating following its promising third quarter results on Oct 30.
Jazz Pharmaceuticals plc (JAZZ) Catches Eye: Stock Rises 8% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Dec 23, 6:44AM CST
Jazz Pharmaceuticals Public Limited Company was a big mover last session, as the company saw its shares gain 8% on the day.
Ariad Pharmaceuticals (ARIA) Worth Watching: Stock Surges 19.7% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Dec 19, 6:44AM CST
Ariad Pharmaceuticals Inc. was a big mover last session, as the company saw its shares jump nearly 20% on the day.
Surging Rank, Surging Stock: Why InSite Vision (INSV) is a Winner? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Dec 18, 6:30AM CST
One company that should be on your radar is InSite Vision Incorporated. The stock of this company has seen its Zacks Rank surge over the past four weeks, moving from Hold to its current position as a Strong Buy.
(0)
(0)